tradingkey.logo

KORU Medical Systems Inc

KRMD
4.920USD
+0.050+1.03%
Close 02/06, 16:00ETQuotes delayed by 15 min
227.76MMarket Cap
LossP/E TTM

KORU Medical Systems Inc

4.920
+0.050+1.03%

More Details of KORU Medical Systems Inc Company

KORU Medical Systems, Inc. is a medical technology company. The Company is focused on developing, manufacturing, and commercializing patient-centric large volume subcutaneous infusion solutions primarily for the subcutaneous drug delivery market. The Company is focused on its mechanical infusion products, the FREEDOM Infusion Systems (FREEDOM System), which include the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. The Company’s infusion devices work together as a system to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD) and chronic inflammatory demyelinating polyneuropathy (CIDP). The FREEDOM System operates at a lower pressure than an electrical, volumetric pump and maintains a balance between what a patient’s subcutaneous tissues can tolerate and what the system delivers.

KORU Medical Systems Inc Info

Ticker SymbolKRMD
Company nameKORU Medical Systems Inc
IPO dateOct 27, 1993
CEOTharby (Linda M)
Number of employees80
Security typeOrdinary Share
Fiscal year-endOct 27
Address100 Corporate Drive
CityMAHWAH
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code07430
Phone18454692042
Websitehttps://www.korumedical.com/
Ticker SymbolKRMD
IPO dateOct 27, 1993
CEOTharby (Linda M)

Company Executives of KORU Medical Systems Inc

Name
Name/Position
Position
Shareholding
Change
Ms. Linda M. Tharby
Ms. Linda M. Tharby
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.12M
+29463.00%
Mr. Adam Kalbermatten
Mr. Adam Kalbermatten
Chief Commercial Officer
Chief Commercial Officer
300.00K
+300000.00%
Mr. Shahriar (Shar) Matin
Mr. Shahriar (Shar) Matin
Independent Director
Independent Director
94.10K
+2581.00%
Dr. Donna French, Ph.D.
Dr. Donna French, Ph.D.
Independent Director
Independent Director
91.47K
+2581.00%
Mr. Robert A. (Rob) Cascella
Mr. Robert A. (Rob) Cascella
Independent Director
Independent Director
91.11K
+2581.00%
Mr. Christopher (Chris) Pazdan
Mr. Christopher (Chris) Pazdan
Chief Operating Officer
Chief Operating Officer
49.99K
+26904.00%
Mr. Edward Wholihan
Mr. Edward Wholihan
Director
Director
44.27K
+2581.00%
Mr. Joseph M. Manko, Jr., J.D.
Mr. Joseph M. Manko, Jr., J.D.
Independent Director
Independent Director
--
--
Mr. R. John Fletcher
Mr. R. John Fletcher
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Thomas (Tom) Adams
Mr. Thomas (Tom) Adams
Chief Financial Officer, Treasurer, Corporate Secretary
Chief Financial Officer, Treasurer, Corporate Secretary
--
--
Name
Name/Position
Position
Shareholding
Change
Ms. Linda M. Tharby
Ms. Linda M. Tharby
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.12M
+29463.00%
Mr. Adam Kalbermatten
Mr. Adam Kalbermatten
Chief Commercial Officer
Chief Commercial Officer
300.00K
+300000.00%
Mr. Shahriar (Shar) Matin
Mr. Shahriar (Shar) Matin
Independent Director
Independent Director
94.10K
+2581.00%
Dr. Donna French, Ph.D.
Dr. Donna French, Ph.D.
Independent Director
Independent Director
91.47K
+2581.00%
Mr. Robert A. (Rob) Cascella
Mr. Robert A. (Rob) Cascella
Independent Director
Independent Director
91.11K
+2581.00%
Mr. Christopher (Chris) Pazdan
Mr. Christopher (Chris) Pazdan
Chief Operating Officer
Chief Operating Officer
49.99K
+26904.00%

Revenue Breakdown

Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
By BusinessUSD
Name
Revenue
Proportion
Domestic Core
6.12M
58.86%
International Core
3.70M
35.53%
Novel Therapies
584.27K
5.62%
By RegionUSD
Name
Revenue
Proportion
Domestic
6.71M
64.47%
International
3.70M
35.53%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Domestic Core
6.12M
58.86%
International Core
3.70M
35.53%
Novel Therapies
584.27K
5.62%

Shareholding Stats

Updated: Thu, Feb 5
Updated: Thu, Feb 5
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Horton Capital Management LLC
12.68%
First Light Asset Management, LLC
9.77%
Topline Capital Management, LLC
7.88%
The Vanguard Group, Inc.
4.77%
Tharby (Linda M)
4.58%
Other
60.33%
Shareholders
Shareholders
Proportion
Horton Capital Management LLC
12.68%
First Light Asset Management, LLC
9.77%
Topline Capital Management, LLC
7.88%
The Vanguard Group, Inc.
4.77%
Tharby (Linda M)
4.58%
Other
60.33%
Shareholder Types
Shareholders
Proportion
Hedge Fund
22.17%
Investment Advisor
17.32%
Investment Advisor/Hedge Fund
16.24%
Individual Investor
8.54%
Pension Fund
0.84%
Research Firm
0.33%
Bank and Trust
0.10%
Insurance Company
0.01%
Other
34.45%

Institutional Shareholding

Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
179
26.41M
57.01%
-1.20M
2025Q3
175
25.43M
54.99%
-237.14K
2025Q2
181
28.37M
61.38%
+1.59M
2025Q1
185
26.98M
58.55%
-3.80M
2024Q4
166
28.05M
61.23%
-2.99M
2024Q3
157
26.45M
57.75%
-1.49M
2024Q2
155
27.99M
61.12%
-3.90M
2024Q1
138
29.57M
64.66%
-1.94M
2023Q4
141
31.83M
69.81%
-3.05M
2023Q3
138
32.73M
71.92%
-2.69M
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Horton Capital Management LLC
5.87M
12.68%
-16.19K
-0.27%
Apr 02, 2025
First Light Asset Management, LLC
4.53M
9.77%
-153.89K
-3.29%
Sep 30, 2025
Topline Capital Management, LLC
3.65M
7.88%
+39.89K
+1.11%
Sep 30, 2025
The Vanguard Group, Inc.
2.15M
4.63%
+60.11K
+2.88%
Sep 30, 2025
Tharby (Linda M)
2.12M
4.58%
+29.46K
+1.41%
Oct 16, 2025
BlackRock Institutional Trust Company, N.A.
1.93M
4.17%
+266.62K
+16.00%
Sep 30, 2025
Geode Capital Management, L.L.C.
1.01M
2.17%
+9.65K
+0.97%
Sep 30, 2025
Meros Investment Management, LP
848.90K
1.83%
-1.49K
-0.18%
Sep 30, 2025
Empire Financial Management Company, LLC
824.53K
1.78%
+824.53K
--
Sep 30, 2025
Archon Capital Management LLC
700.15K
1.51%
--
--
Sep 30, 2025
View more

Related ETFs

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Micro-Cap ETF
0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.03%
iShares Russell 2000 ETF
0.01%
Global X Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
ProShares Hedge Replication ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
0%
DFA Dimensional US Sustainability Core 1 ETF
0%
View more
iShares Micro-Cap ETF
Proportion0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proportion0.03%
iShares Russell 2000 ETF
Proportion0.01%
Global X Russell 2000 ETF
Proportion0.01%
Proshares Ultra Russell 2000
Proportion0.01%
ProShares Hedge Replication ETF
Proportion0.01%
iShares Russell 2000 Growth ETF
Proportion0.01%
ProShares UltraPro Russell2000
Proportion0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
Proportion0%
DFA Dimensional US Sustainability Core 1 ETF
Proportion0%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Splits

Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
KeyAI